AI Genomics
- Korean Biotech Takes Home-Built Strengths to BIO USA 2026
At BIO USA 2026, Korean biotech leaders from MediSapiens, G2G Bio and Lotte Biologics pitched global partners on capabilities built at home.
At BIO USA 2026, Korean biotech leaders from MediSapiens, G2G Bio and Lotte Biologics pitched global partners on capabilities built at home.